<DOC>
	<DOCNO>NCT01896505</DOCNO>
	<brief_summary>The purpose research study find information : determine effect high low fat food pharmacokinetics ( PK ) oral KPT-330 tablet , compare PK capsule tablet , assess effect KPT-330 cellular morphology biomarker change sarcoma biopsy specimen ( patient safely undergo biopsy ) .</brief_summary>
	<brief_title>A Phase I Trial Assess Effects Food Formulation PK KPT-330 Patients With Sarcoma</brief_title>
	<detailed_description />
	<mesh_term>Sarcoma</mesh_term>
	<criteria>1 . Patients must histologically confirm soft tissue bone/cartilage sarcoma . Patients sarcoma small round blue cell tumor type allow . Gastrointestinal stromal tumor ( GIST ) exclude . 2 . Patients must receive least one prior anticancer regimen metastatic disease unless therapy available evidence progressive disease study entry . Patients stable disease include failure respond another drug ( ) within previous 3 month 1 . Patients know liver metastasis 2 . Radiation , chemotherapy , immunotherapy , systemic anticancer therapy participation investigational anticancer study â‰¤ 3 week prior initiation therapy 3 . Patients know brain metastasis 4 . Patients gastrointestinal dysfunction could interfere interpretation food effect data 5 . Patients know intolerance low high fat meal 6 . In opinion investigator , patient significantly ideal body weight</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>bone</keyword>
	<keyword>soft-tissue</keyword>
	<keyword>sarcoma</keyword>
	<keyword>KPT-330</keyword>
	<keyword>food</keyword>
	<keyword>effect</keyword>
	<keyword>Selinexor</keyword>
</DOC>